ArticleMolecular cancer therapeutics2024

The Vedotin Antibody-Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles.

Haley D Neff-LaFord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.